Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
DMI BioSciences, Inc. is a privately-held biopharmaceutical company based in Englewood, Colorado, that discovers and develops small molecule and peptide-based pharmaceuticals and biomarkers for acute and chronic inflammation. DMI focuses on immunologic, vascular and CNS diseases, including acute coronary syndrome, multiple sclerosis, Alzheimer’s disease, asthma and cancer. DMI is co-developing several of its drug candidates with industry partners. Two of DMI’s drug candidates are currently in human clinical trials. DMI’s strategy is to develop pharmaceutical compounds and biomarkers through preclinical and early-stage clinical development and collaborate with financial and industry partners for later-stage development and commercialization. ( www.dmibio.com )
DMI BioSciences Inc
1999 North Fitzsimons Parkway, Suite 100
Aurora, Colorado 80045-7503
USA
Tel: (303) 418-1000
Fax: (303) 418-1001